ICON plc is a global provider of outsourced drug development and commercialisation services to pharmaceutical, biotechnology, medical device, and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently operates from 93 locations in 37 countries and has approximately 13,650 employees.

Full Service Portfolio: Early Phase to Commercialisation

Early Phase Services

Clinical Research Unit
Patient Studies
Pharmacodynamic Models
Data Visualisation & Analysis
NONMEM Software
PK/PD Pop Software
Precision Methodology Cardiac Assessment

Drug Development Services

Chemistry, Manufacturing & Controls (CMC)
Clinical Development

Functional Services

Government & Public Health Solutions

Laboratory Services

Central Laboratories
Bioanalytical Laboratories

Clinical Research Services

Project Management
Clinical Operations/Monitoring
Patient Centric Monitoring
Data Management

Site & Patient Solutions

Integrated Site Network
Patient Identification & Matching
Patient Recruitment & Engagement
Digital Solutions – FIRECREST

Scientific Operations

Adaptive Trials – ADDPLAN
Medical Imaging – MIRA
Medical Affairs
Regulatory Affairs
Endpoint Adjudication Services
Medical Writing & Publishing
Interactive Response Technology – FLEX ADVANTAGE

Commercialisation & Outcomes

Real World Strategy Evidence & Analytics
Real World Evidence & Late Phase Research
Global Research Services Hubs
Access, Commercialisation & Communications
Patient Centered Sciences
Strategic Regulatory Services
Medical Device & Diagnostics Research